Here are five highlights:
1. A titanium expandable interbody device, the Xsert System expands in-situ.
2. Xtant offers the system in different size and lordotic angulations to complement various patient anatomies.
3. Intended for use at one or two contiguous levels, the system is designed to ease insertion techniques as well as provide implant height adjustability.
4. The Xsert System is cleared for use with autograft or allograft bone graft.
5. Xtant is planning an initial product launch in mid-2017.
More articles on devices:
Sports Medicine Complex set for Michigan’s upper peninsula: 3 things to know
Amedica appoints new sales exec, receives FDA clearance for Taurus system: 5 things to note
5 takeaways on global non-fusion spinal devices market: Medtronic, Stryker, Zimmer Biomet & DePuy Synthes dominate
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
